German specialists probing 10 deaths of people vaccinated against Covid-19

Representative image

Specialists from Germany's Paul Ehrlich Institute are looking into the deaths of 10 people who passed away soon after having been inoculated against the novel coronavirus disease, Brigitte Keller-Stanislawski, the head of the institute's department of safety of medicinal products and medical devices, said on Thursday.

According to the medical expert, the deceased were aged from 79 to 93, all with antecedent diseases. The time between vaccination and death ranged from several hours to four days.

"Until yesterday we had nine cases; we have to wait for the data from Lower Saxony [about another alleged case], then there will be 10. We are talking about patients in extremely grave condition, with multiple diseases, who were receiving palliative treatment. I have already said that we are studying these cases ... Based on our current data we assume they died from their main diseases, coinciding in time with the vaccination," Keller-Stanislawski said at a press conference.

In late December, Germany launched a vaccination campaign against COVID-19, using the vaccine developed by companies Pfizer and BioNTech. As of this day, 842,000 people have received the vaccine. The first ones to get vaccinated are those over 80, residents and staff at nursing homes as well as medical personnel.

The institute also reported six anaphylaxis cases. So far, there have been 325 cases of side-effects allegedly related to the vaccine, including 51 severe ones. Keller-Stanislawski stated that those results are within expectations and correspond to the US vaccination statistics.


(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel